Trial Profile
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (ICAC-20)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Fluticasone propionate (Primary) ; Omalizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms PROSE
- 23 May 2018 Results of a post-hoc analysis presented at the 114th International Conference of the American Thoracic Society.
- 01 Sep 2017 Results (n=92) of patients from two trial centers were published in the Journal of Allergy and Clinical Immunology
- 13 Jun 2017 Results published in the American Journal of Respiratory and Critical Care Medicine